New T cell–based immunotherapy shows promise for lethal stem cell transplant complication

Share :
Published: 27 Apr 2015
Views: 2209
Rating:
Save
Dr Richard O'Reilly - Memorial Sloan Kettering Cancer Center, New York, USA

Dr O'Reilly presents on his work looking at the development of Epstein-Barr virus– specific cytotoxic T lymphocyte (EBV-CTL) therapy in the treatment of leukaemia and lymphoma during a press conference at AACR 2015.

Read the news story for more.